Systematic administration of IL-1 signal inhibitors is a direct strategy, but long-term blockage of IL-1 signal increases the risk for serious infection [240, 241], because this strategy eliminates pro-inflammatory IL-1 signal roughly, which is crucial for innate and adaptive immunity. The gene discussed is IL1A; the disease is infection.